Lawsuit Alleges USDA Secretly Relaxed Animal Welfare Inspections

A Harvard Law School lawsuit filed on behalf of animal welfare organizations accuses the United States Department of Agriculture of offloading the burden of inspecting animal research sites to a private third party, resulting in a system that the lawsuit describes as largely self-policing and less rigorous.

Written byDan Robitzski
| 5 min read
White rabbits are held in place with transparent restraints in a research laboratory
Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

On Tuesday (April 5), the Harvard Law School Animal Law & Policy Clinic filed a suit against the United States Department of Agriculture for, it says, evading “its statutory obligation to conduct full annual inspections of research facilities as required under the Animal Welfare Act.”

The lawsuit, which was filed on behalf of the animal welfare organizations Rise for Animals and the Animal Legal Defense Fund, centers around the USDA’s decision to change how it handles inspecting research facilities that house animals for scientific study. Instead of conducting a full annual inspection itself, the agency decided to hire a third-party organization called the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International in February 2019, according to internal documents obtained through the Harvard team’s FOIA requests that were described in the suit and in an interview with The Scientist. But the USDA never publicly announced the change, which ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • black and white image of young man in sunglasses with trees in background

    Dan is an award-winning journalist based in Los Angeles who joined The Scientist as a reporter and editor in 2021. Ironically, Dan’s undergraduate degree and brief career in neuroscience inspired him to write about research rather than conduct it, culminating in him earning a master’s degree in science journalism from New York University in 2017. In 2018, an Undark feature Dan and colleagues began at NYU on a questionable drug approval decision at the FDA won first place in the student category of the Association of Health Care Journalists' Awards for Excellence in Health Care Journalism. Now, Dan writes and edits stories on all aspects of the life sciences for the online news desk, and he oversees the “The Literature” and “Modus Operandi” sections of the monthly TS Digest and quarterly print magazine. Read more of his work at danrobitzski.com.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies